ARPP-21 inhibitors belong to a distinct chemical class that primarily targets the regulation of synaptic plasticity in neuronal cells. At the heart of this class is the protein ARPP-21 (cAMP-regulated phosphoprotein 21), which plays a pivotal role in modulating various intracellular signaling pathways critical for synaptic function and neurotransmission. The inhibitors specifically aim to impede the activity of ARPP-21, thereby influencing the intricate balance of phosphorylation and dephosphorylation events within neurons.
ARPP-21 inhibitors often feature unique molecular scaffolds designed to interact with the catalytic site of ARPP-21 or disrupt its binding with key cellular partners. These compounds may possess diverse chemical functionalities, including aromatic rings, heterocyclic structures, and polar moieties, enabling them to engage in specific interactions with the target protein. The mechanism of action involves interference with the phosphorylation status of ARPP-21, affecting downstream signaling cascades involved in synaptic transmission. By modulating the function of ARPP-21, these inhibitors offer a means to explore and potentially manipulate the plasticity of synapses, contributing to a deeper understanding of cellular communication in the nervous system. Ongoing research endeavors seek to elucidate the structural nuances of ARPP-21 inhibitors and their precise impact on synaptic dynamics, opening avenues for the development of novel tools for neuroscience research and providing insights into the intricate molecular mechanisms governing neuronal communication.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels, which may counteract the effects of ARPP21-mediated PP1 regulation. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
Inhibits protein kinase A (PKA), which could modulate the phosphorylation state of ARPP21 and its interaction with PP1. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
A potent inhibitor of PP1, it can disrupt the ARPP21-PP1 interaction by binding to PP1 directly. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Another PP1 inhibitor, can alter the phosphatase activity that ARPP21 is associated with. | ||||||
Rp-cAMPS | 151837-09-1 | sc-24010 | 1 mg | $203.00 | 37 | |
A cAMP analog that inhibits PKA, could influence ARPP21's role in PP1 regulation. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $138.00 $220.00 $972.00 | 47 | |
A PKA inhibitor, could modify ARPP21's regulatory effects on PP1. | ||||||
Sangivamycin | 18417-89-5 | sc-204261 sc-204261A sc-204261B sc-204261C sc-204261D sc-204261E | 1 mg 10 mg 25 mg 50 mg 100 mg 250 mg | $333.00 $1348.00 $2611.00 $5212.00 $9894.00 $20298.00 | ||
A nucleoside analog that can inhibit various kinases, potentially altering ARPP21's function. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
A PP1 inhibitor that could potentially modulate the activity of ARPP21 indirectly. | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $49.00 $203.00 | 1 | |
Disrupts PP1 activity and thus may affect ARPP21's regulatory functions. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $92.00 $256.00 | 5 | |
A bisphosphonate that can affect several kinase pathways, possibly influencing ARPP21 indirectly. | ||||||